Computational and experimental analyses of mammalian arylamine N-acetyltransferase structure and function

Drug Metabolism and Disposition

Volumn 35, Issue 6, 2007, Pages 1001-1007

  Walraven, Jason M ^a   Trent, John O ^a   Hein, David W ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; EVOLUTIONARY HOMOLOGY; MAMMAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM; THERMOSTABILITY;

ALPHAPROTEOBACTERIA; AMINO ACID SEQUENCE; ARYLAMINE N-ACETYLTRANSFERASE; BACTERIAL PROTEINS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN STRUCTURE, SECONDARY; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; SEQUENCE HOMOLOGY, AMINO ACID; SULFAMETHAZINE;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 34249071417     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.015040     Document Type: Article

References (43)

1. Adamczak R, Porollo A, and Meller J (2005) Combining Prediction of Secondary Structure and Solvent Accessibility in Proteins. Proteins 59:467-475.
2. Barker DF, Husain A, Neale JR, Martini BD, Zhang X, Doll MA, States JC, and Hein DW (2006) Functional properties of an alternative, tissue-specific promoter for human arylamine Nacetyltransferase 1. Pharmacogenet Genomics 16:515-525.
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Cheng J, Randall A, Sweredoski M, and Baldi P (2005) SCRATCH: a protein structure and structural feature prediction server. Nucleic Acids Res 33:72-76.
5. Chung CT and Miller RH (1988) A rapid and convenient method for the preparation and storage of competent bacterial cells. Nucleic Acids Res 16:3580.
6. Chung CT, Niemela SL, and Miller RH (1989) One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc Natl Acad Sci USA 86:2172-2175.
7. Cuff JA and Barton GJ (2000) Application of multiple sequence alignment profiles to improve protein secondary structure prediction. Proteins 40:502-511.
8. Doll MA and Hein DW (1995) Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred rats. Pharmacogenetics 5:247-251.
9. Ferguson RJ, Doll MA, Rustan TD, Gray K, and Hein DW (1994) Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles. Drug Metab Dispos 22:371-376.
10. Grant DM, Blum M, Beer M, and Meyer UA (1991) Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 39:184-191.
11. Hanna PE (1996) Metabolic activation and detoxification of arylamines. Curr Med Chem 3:195-210.
12. Hein DW (1988) Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 948:37-66.
13. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, and Feng Y (2000) Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 9:29-42.
14. Holton SJ, Dairou J, Sandy J, Rodrigues-Lima F, Dupret J-M, Noble ME, and Sim E (2005) Structure of Mesorhizobium loti arylamine N- acetyltransferase 1. Acta Crystallogr Sect F Struct Biol Cryst Commun 61:14-16.
15. Horton RM, Hunt HD, Ho SN Pullen JK, Pease LR (1989) Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68.
16. Husain A, Zhang X, Doll MA, States JC, Barker DF, and Hein DW (2007) Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues. Drug Metab Dispos 35:721-727.
17. Karplus K, Barret C, and Hughey R (1998) Hidden (Markov) models for detecting remote protein homologies. Bioinformatics 14:846-856.
18. Kawamura A, Graham J, Mushtaq A, Tsiftsoglou SA, Vath GM, Hanna PE, Wagner CR, and Sim E (2005) Eukaryotic arylamine N-acetyltransferase investigation of substrate specificity by high-throughput screening. Biochem Pharmacol 69:347-359.
19. Kneller DG, Cohen FE, and Langridge R (1990) Improvements in protein secondary structure prediction by an enhanced neural network. J Mol Biol 214:171-182.
20. Lau EY, Felton JS, and Lightstone FC (2006) Insights into the O-acetylation reaction of hydroxylated heterocyclic amines by human arylamine N-acetyltransferases: a computational study. Chem Res Toxicol 19:1182-1190.
21. Leff MA, Epstein PN, Doll MA, Fretland AJ, Devanaboyina US, Rustan TD, and Hein DW (1999) Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouse. J Pharmacol Exp Ther 290:182-187.
22. Lin K, Simossis VA, Taylor WR, and Heringa J (2005) A simple and fast secondary structure prediction algorithm using hidden neural networks. Bioinformatics 21:152-159.
23. McClelland JL and Rumelhart DE (1988) Explorations in Parallel Distributed Processing, vol 3, pp 318-362. MIT Press, Cambridge, MA.
24. McGuffin LJ, Bryson K, and Jones DT (2000) The PSIPRED protein structure prediction server. Bioinformatics 16:404-405.
25. Meiler J, Muller M, Zeidler A, and Schmaschke F (2001) Generation and evaluation of dimension-reduced amino acid parameter representations by artificial neural networks. J Mol Model 7:360-369.
26. Minchin RF (1995) Acetylation of para-aminobenzoylglutamate, a folate catabolite, by recombinant human NAT and U937 cells. Biochem J 307:1-3.
27. Mushtaq A, Payton M, and Sim E (2002) The COOH terminus of arylamine N-acetyltransferase from Salmonella typhimurium controls enzymatic activity. J Biol Chem 277:12175-12181.
28. O'Sullivan O, Suhre K, Abergel C, Higgins DG, and Notredame C (2004) 3DCoffee: combining protein sequences and structures within multiple sequence alignments. J Mol Biol 340:385-395.
29. Ouali M and King RD (2000) Cascaded multiple classifiers for secondary structure prediction. Prot Sci 9:1162-1176.
30. Paul C and Rosenbusch JP (1985) Folding patterns of porin and bacteriorhodopsin. EMBO J 4:1593-1597.
31. Payton M, Mushtaq A, Yu T-W, Wu L-J, Sinclair J, and Sim E (2001) Eubacterial arylamine N-acetyltransferase identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine, and aspartate residues. Microbiology 147:1137-1147.
32. Pollastri G and McLysaght A (2005) Porter: a new, accurate server for protein secondary structure prediction. Bioinformatics 21:1719-1720.
33. Raghava GPS (2002) APSSP2 : a combination method for protein secondary structure prediction based on neural network and example based learning. CASP5. A-132.
34. Rodrigues-Lima F, Delomenie C, Goodfellow GH, Grant DM, and Dupret J-M (2001) Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence of the conservation of a cysteine protease catalytic domain and an active site loop. Biochem J 356:327-334.
35. Rodrigues-Lima F and Dupret J-M (2002) 3D model of human arylamine N-acetyltransferase 2: structural basis of the slow acetylator phenotype of the R64Q variant and analysis of the active-site loop. Biochem Biophys Res Commun 291:116-123.
36. Rost B (1996) PHD: predicting one-dimensional protein structure by profile based neural networks. Methods Enzymol 266:525-539.
37. Sali A and Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779-815.
38. Sandy J, Mushtaq A, Kawamura A, Sinclair J, Sim E, and Noble M (2002) The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis - an enzyme which inactivates the anti-tubercular drug, isoniazid. J Mol Biol 318:1071-1083.
39. Savulescu MR, Mushtaq A, and Josephy PD (2005) Screening and characterizing human NAT2 variants. Methods Enzymol 400:192-215.
40. Sinclair JC, Sandy J, Delgoda R, Sim E, and Noble ME (2000) Structure of arylamine N-acetyltransferase reveals a catalytic triad. Nat Struct Biol 7:560-564.
41. Walraven JM, Doll MA, and Hein DW (2006) Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2. J Pharmacol Exp Ther 319:369-375.
42. Weber WW and Hein DW (1985) N-Acetylation pharmacogenetics. Pharmacol Rev 37:25-27.
43. Westwood IM, Holton SJ, Rodrigues-Lima F, Dupret J-M, Bhakta S, Noble ME, and Sim E (2005) Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase. Biochem J 385:605-612.